VYGR

Conviction 20HealthcareScan · Mon, Aug 10, 2026

VYGR$3.17-3.06%

ResistanceSupportVol 14

Vol MA14 608.22K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Voyager Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.voyagertherapeutics.com ↗

Price3.17

Change-3.06%

Gap-1.22%

Rel volume2.07×

Avg volume645.22K

Avg $ vol2.01M

SMA 203.11

SMA 503.39

SMA 2003.87

Price vs 50-6.60%

Price vs 200-18.14%

MA stackbearish

50/200 cross—

Supertrenddown · 3.55

RSI (14)47

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D57 / 69

ADX (14)18

+DI / −DI18 / 15

RSI divergence—

MACD divergence—

ATR %+5.39%

ADR %5.24%

52w high5.33

52w low3.00

From 52w high-40.53%

Above 52w low+5.67%

New 52w highNo

SqueezeOn · 3d

Bollinger width8.65%

%B0.74

Donchian pos56.63%

Donchian high3.35

Donchian low2.94

AVWAP (52w high)3.96

vs AVWAP high-20.04%

AVWAP (52w low)3.15

vs AVWAP low+0.71%

OBV trendDown

Chaikin MF (20)-0.03

Today vs 20d2.07×

Avg vol (14d)608.22K

Avg vol (20d)645.22K

Avg $ vol (20d)2.01M

Market cap195.33M

RS 3m (vs SPY)-23.12%

RS 6m (vs SPY)-21.74%

RS line new highNo

Trend template0/8

Technical rank21.8

1 week+5.67%

1 month-7.85%

3 months-21.73%

6 months-13.86%

1 year-1.55%

YTD-21.34%

P/E-1.63

P/B1.27

P/S4.84

P/FCF-1.45

EPS-2.04

Div yield—

ROE-77.55%

ROA-60.54%

Debt/Eq—

Current7.51

EV/EBITDA—

Gross margin—

Net margin-296.53%

Rev growth-49.53%

EPS growth-84.18%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value159.56M

Revenue3.17M

Net income-24.47M

Gross profit—

Free cash flow-135.06M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out60.42M

Employees141

ListedWed, Nov 11, 2015

Free float43.6M

Float %78.4%

Short interest3.84M

Days to cover4.6d

Short volume50.4%

Squeeze score62 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank21.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.86

Support2.96

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VYGR

All disclosures →

No recent disclosed trades by Congress in VYGR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VYGR

No recent insider (Form 4) filings in VYGR. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VYGR · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.